These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3349791)

  • 1. Variability in aminoglycoside pharmacokinetics in critically ill surgical patients.
    Dasta JF; Armstrong DK
    Crit Care Med; 1988 Apr; 16(4):327-30. PubMed ID: 3349791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrapatient variation of aminoglycoside pharmacokinetics in critically ill surgery patients.
    Fuhs DW; Mann HJ; Kubajak CA; Cerra FB
    Clin Pharm; 1988 Mar; 7(3):207-13. PubMed ID: 3356116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetics of aminoglycosides in critically ill trauma patients on once-daily regimens.
    Barletta JF; Johnson SB; Nix DE; Nix LC; Erstad BL
    J Trauma; 2000 Nov; 49(5):869-72. PubMed ID: 11086778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of aminoglycosides in critically ill patients: individualization of dosage using Bayesian statistics and pharmacokinetic principles.
    Böttger HC; Oellerich M; Sybrecht GW
    Ther Drug Monit; 1988; 10(3):280-6. PubMed ID: 3176103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered aminoglycoside pharmacokinetics in the critically ill.
    Beckhouse MJ; Whyte IM; Byth PL; Napier JC; Smith AJ
    Anaesth Intensive Care; 1988 Nov; 16(4):418-22. PubMed ID: 3232800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased aminoglycoside dosage requirements in hematologic malignancy.
    Zeitany RG; El Saghir NS; Santhosh-Kumar CR; Sigmon MA
    Antimicrob Agents Chemother; 1990 May; 34(5):702-8. PubMed ID: 2360811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of estimating individual pharmacokinetic data for aminoglycoside therapy in seriously ill patients.
    Denaro CP; Ravenscroft PJ
    Aust N Z J Med; 1987 Oct; 17(5):526-32. PubMed ID: 3446165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
    Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
    Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aminoglycoside pharmacokinetics in African-Americans with normal renal function.
    Oparaoji EC; Siram S; Elemihe U; Mezghebe HM; Cho T; Bashiri M; Piedrahita K; Pipalla RS
    J Clin Pharm Ther; 1998 Jun; 23(3):191-7. PubMed ID: 9831970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum level-adjusted dosage of once-daily aminoglycoside therapy in critical illness: results of a prospective study].
    Reimann IR; Meier-Hellmann A; Pfeifer R; Traut T; Schilling A; Stein G; Reinhart K; Hoffmann A
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 May; 34(5):288-95. PubMed ID: 10372218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of pharmacokinetic sampling methods on aminoglycoside dosing in critically ill surgery patients.
    Mann HJ; Wittbrodt ET; Baghaie AA; Cerra FB
    Pharmacotherapy; 1998; 18(2):371-8. PubMed ID: 9545157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminoglycosides in intermittent hemodialysis: pharmacokinetics with individual dosing.
    Dager WE; King JH
    Ann Pharmacother; 2006 Jan; 40(1):9-14. PubMed ID: 16332944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum aminoglycoside clearance is predicted as poorly by renal aminoglycoside clearance as by creatinine clearance in critically ill patients.
    Hickling KG; Begg EJ; Perry RE; Atkinson HC; Sharman JR
    Crit Care Med; 1991 Aug; 19(8):1041-7. PubMed ID: 1860329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between hemodynamic and vital support measures and pharmacokinetic variability of amikacin in critically ill patients with sepsis.
    Lugo G; Castañeda-Hernández G
    Crit Care Med; 1997 May; 25(5):806-11. PubMed ID: 9187600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminoglycoside pharmacokinetic parameters in neurocritical care patients undergoing induced hypothermia.
    Mercer JM; Neyens RR
    Pharmacotherapy; 2010 Jul; 30(7):654-60. PubMed ID: 20575630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of glomerular filtration rate using aminoglycoside clearance in critically ill medical patients.
    Zarowitz BJ; Robert S; Peterson EL
    Ann Pharmacother; 1992 Oct; 26(10):1205-10. PubMed ID: 1421639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosage adjustment of antiinfective therapy in patients with renal impairment.
    Eckhardt A; Borner K; Keller F; Zellner D
    Int J Clin Pharmacol Ther; 1997 Mar; 35(3):99-102. PubMed ID: 9088997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A practical alternative to conventional aminoglycoside dosing methods.
    Goldman MP; Fuller MA
    Ann Pharmacother; 1993 Nov; 27(11):1333-9. PubMed ID: 8286803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of aminoglycosides in elderly patients. Pharmacokinetic and clinical considerations.
    Mörike K; Schwab M; Klotz U
    Drugs Aging; 1997 Apr; 10(4):259-77. PubMed ID: 9108987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic variability of extended interval tobramycin in burn patients.
    Bracco D; Landry C; Dubois MJ; Eggimann P
    Burns; 2008 Sep; 34(6):791-6. PubMed ID: 18395988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.